Universal Display Investing Activities - Other 2010-2024 | OLED
Universal Display annual/quarterly investing activities - other history and growth rate from 2010 to 2024. Investing activities - other can be defined as the net amount of items a company reports that are too small to report separately. Additionally, this field holds the sum of items a company reports that cannot be assigned to any other standardized field in the investing activities section of the Cash Flows Statement
- Universal Display investing activities - other for the quarter ending December 31, 2024 was $M, a NAN% increase year-over-year.
- Universal Display investing activities - other for the twelve months ending December 31, 2024 was $0M, a NAN% increase year-over-year.
- Universal Display annual investing activities - other for 2024 was $0B, a NAN% decline from 2023.
- Universal Display annual investing activities - other for 2023 was $0B, a NAN% decline from 2022.
- Universal Display annual investing activities - other for 2022 was $0B, a NAN% decline from 2021.
Universal Display Annual Investing Activities - Other (Millions of US $) |
2024 |
$ |
2023 |
$ |
2022 |
$ |
2021 |
$ |
2020 |
$ |
2019 |
$ |
2018 |
$ |
2017 |
$ |
2016 |
$ |
2015 |
$ |
2014 |
$ |
2013 |
$ |
2012 |
$ |
2011 |
$ |
2010 |
$ |
2009 |
$ |
Sector |
Industry |
Market Cap |
Revenue |
Computer and Technology |
Miscelleneous Electrical Components |
$7.495B |
$0.648B |
Universal Display Corporation is a leading developer of technology and intellectual property (IP) for the Organic Light Emitting Diodes (OLED) market. OLEDs are thin, lightweight and power-efficient solid-state devices that emit light. This can be manufactured on both flexible and rigid substrates, making them highly suitable for use in full-color displays and also as lighting products. The company reports operations mainly under three heads, namely Material sales, Royalty and license fees and Contract research services. Material sales include revenues from both phosphorescent emitter and host materials. Royalty and license fees include fee payments under patent license agreement with SDC, and licensed sales and royalties from customers. Contract research services include revenues earned by Adesis, which performs organic and organometallic synthetics research, development and commercialization on a contractual basis for the company's customers.
|